Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Oct 3, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to detect serious brain conditions called cerebral ischemia, which can occur after a specific type of brain bleed known as subarachnoid hemorrhage. Researchers want to see if using advanced computer technology (machine learning) and specific markers found in blood and spinal fluid can help identify when a patient’s brain might be in danger. The study will look at various factors, such as heart rate patterns and brain activity, to understand how well a patient's brain is functioning.

To participate in this trial, individuals need to be over 18 years old and have been admitted to the intensive care unit with a brain bleed due to an aneurysm. Unfortunately, those who cannot give consent, have heart rhythm issues, or have had previous brain damage cannot take part. While the study is not recruiting participants yet, it aims to provide better ways to monitor and care for patients with these serious conditions, potentially improving outcomes and recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over the age of 18 with aneurysmal subarachnoid hemorrhage admitted to intensive care units at Sahlgrenska University hospital.
• Exclusion Criteria:
• • Unable to consent,
• • Cardiac arrythmia,
• • Previous brain damage